We are live on ! Find out more
LHR

Lunate Holding RSC Portfolio holdings

AUM $211M
This Fund
S&P 500
This Quarter Est. Return
-3.88%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$211M
AUM Growth
–
Cap. Flow
+$228M
Cap. Flow %
108.24%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$111M
2
BIRK icon
Birkenstock
BIRK
+$51.2M
3
LINE
Lineage Inc
LINE
+$40.8M
4
NMRA icon
Neumora Therapeutics
NMRA
+$25.5M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 56.21%
2 Consumer Discretionary 27.13%
3 Real Estate 16.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$46.8B
$96.1M 45.54%
+2,196,200
New +$111M
BIRK icon
2
Birkenstock
BIRK
$5.94B
$57.2M 27.13%
+1,010,000
New +$51.2M
LINE
3
Lineage Inc
LINE
$9.14B
$35.1M 16.66%
+600,000
New +$40.8M
NMRA icon
4
Neumora Therapeutics
NMRA
$289M
$22.5M 10.67%
+2,124,143
New +$25.5M

Similar funds

HPFG
Hart & Patterson Financial Group Amherst, Massachusetts $206M AUM 7.82% 1-Year Est. Return
KC
Kades & Cheifetz Berwyn, Pennsylvania $195M AUM 11.87% 1-Year Est. Return
AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return
SL
SIB LLC New York, New York $190M AUM 9.27% 1-Year Est. Return
QS
Quantitative Strategies Calabasas, California $187M AUM 10.84% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $177M AUM 15.45% 1-Year Est. Return
MWS
Maxwell Wealth Strategies Pleasanton, California $245M AUM 23.39% 1-Year Est. Return

Lunate Holding RSC's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Lunate Holding RSC, which disclosed 4 positions worth $211M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Revolution Medicines: 2,196,200 shares worth $96.1M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, followed by Consumer Discretionary and Real Estate.

  • Lunate Holding RSC's largest Q4 2024 buy was Revolution Medicines: 2,196,200 shares worth $96.1M.
  • Lunate Holding RSC's ten largest holdings make up 100% of its $211M portfolio in Q4 2024.
  • Lunate Holding RSC disclosed 4 positions in Q4 2024, its first 13F filing on record.

Based on Lunate Holding RSC's 13F filing for Q4 2024, filed 14 Feb 2025.